PAR 1.79% 27.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigms Supplementary Phase 2B Data, page-6

  1. 1,990 Posts.
    lightbulb Created with Sketch. 758
    Data is excellent. People have no idea what they are talking about.

    Trial was a success. Simple.

    When doctors can start prescribing this it'll go through the roof. If I had OA and knew I could go to my doctors and had a 1 in 2 chance that it'll work on me - I'd try it!

    Buy, Buy, Buy - HOLD!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.